Alpha Cognition is trading at $9.50, up 5.09%, with no clear company-specific catalyst identified for the October 12 pre-market rise.

  • The price compares with the October 9 close of $9.04.
  • The latest identified company release, dated October 6, announced future presentations of ZUNVEYL clinical and real-world data at two upcoming meetings; that earlier news does not establish the reason for the move.
  • Broader-market context is mixed, no specific market catalyst is established, and pre-market volume details were unavailable.